A detailed history of Harbor Capital Advisors, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 1,965 shares of MRVI stock, worth $10,473. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,965
Holding current value
$10,473
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$6.84 - $9.73 $13,440 - $19,119
1,965 New
1,965 $16,000
Q2 2023

Jul 11, 2023

BUY
$12.09 - $15.0 $46,026 - $57,105
3,807 New
3,807 $47,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $701M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.